Mizuho began coverage on shares of Select Medical (NYSE:SEM – Free Report) in a research report released on Wednesday, Marketbeat.com reports. The firm issued an outperform rating and a $25.00 price objective on the health services provider’s stock.
A number of other research firms also recently weighed in on SEM. UBS Group decreased their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, January 3rd. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. Benchmark raised Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a research note on Monday, February 24th. Finally, Royal Bank of Canada reduced their price objective on shares of Select Medical from $47.00 to $23.00 and set an “outperform” rating for the company in a research report on Monday, February 24th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.80.
Get Our Latest Analysis on SEM
Select Medical Trading Up 0.2 %
Select Medical (NYSE:SEM – Get Free Report) last posted its earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.11). The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. Equities research analysts forecast that Select Medical will post 1.17 earnings per share for the current fiscal year.
Select Medical Cuts Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Monday, March 3rd were given a $0.0625 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.25 annualized dividend and a yield of 1.53%. Select Medical’s payout ratio is 15.15%.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of SEM. Vanguard Group Inc. lifted its stake in Select Medical by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 12,712,990 shares of the health services provider’s stock valued at $239,640,000 after acquiring an additional 131,228 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Select Medical by 1.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 4,431,469 shares of the health services provider’s stock valued at $83,533,000 after purchasing an additional 62,585 shares in the last quarter. Invesco Ltd. boosted its holdings in Select Medical by 48.6% during the fourth quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider’s stock worth $49,838,000 after purchasing an additional 864,852 shares during the last quarter. Geode Capital Management LLC grew its position in Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after purchasing an additional 46,880 shares in the last quarter. Finally, Principal Financial Group Inc. increased its stake in Select Medical by 1.9% in the 4th quarter. Principal Financial Group Inc. now owns 2,403,508 shares of the health services provider’s stock valued at $45,310,000 after buying an additional 45,685 shares during the last quarter. Institutional investors own 89.48% of the company’s stock.
About Select Medical
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Read More
- Five stocks we like better than Select Medical
- 3 Fintech Stocks With Good 2021 Prospects
- 3 High Short Interest Stocks Set to Pop After Tariff Fears Fade
- What is the Shanghai Stock Exchange Composite Index?
- Time to Buy Alibaba and PDD After Tariff Exemptions?
- Profitably Trade Stocks at 52-Week Highs
- 3 Reasons to Like the Look of Amazon Ahead of Earnings
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.